Dimethyl Fumarate Capsule, Delayed Release
Product Images NDC 24979-127

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Dimethyl Fumarate (NDC 24979-127). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (D120)

This is a description of a medication named Dimethyl Fumarate. It is in the form of delayed-release capsules which are to be swallowed whole. Each capsule has 120mg of Dimethyl Fumarate. It is recommended to be taken orally twice a day. The medication should be stored in its original container and protected from light, as well as kept at a temperature of 20-25°C (68-77°F). The product was manufactured by TWi Pharmaceuticals in Taiwan and is distributed by TWi Pharmaceuticals USA in Paramus, New Jersey. The capsules contain color additives, including FDC Yellow No.5.*

FDA Label Image

Image Description (D240)

This is a medication called Dimethyl Fumarate, available in delayed-release capsules of 240 mg for oral administration. It is prescribed to be taken twice a day by swallowing the capsule whole. The medication should be stored in its original container, protected from light at a temperature of 20°C to 25°C (68°F to 77°F). The capsules contain color additives including FDC Yellow No. 5 (tartrazine). The manufacturer is TWi Pharmaceuticals, with the address in the USA and the manufacturing plant located in Taoyuan City, Taiwan.*

FDA Label Image

Image Description (Dtfclinical)

This is a table displaying the percentage of subjects with confirmed progression of disability over time, with a specific definition provided. The data is related to a study comparing the effects of a medication (ethyl fumarate delayed-release capsules 240mg BID) with a placebo. The study involved 409 subjects receiving the medication and 408 receiving the placebo.*

FDA Label Image

Logo (Logo)

FDA Label Image

Tec00-0006-01 (Tec00 0006 01)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.